Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities (2021 - 2023)

Journey Medical (DERM) has disclosed Other financing activities for 3 consecutive years, with $380000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $380000.0, compared with a TTM value of $380000.0 through Dec 2023, up 77.57%, and an annual FY2024 reading of $50000.0, down 89.38% over the prior year.
  • Other financing activities was $380000.0 for Q4 2023 at Journey Medical, up from -$157000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.4 million in Q1 2021 and bottomed at -$157000.0 in Q2 2022.
  • Average Other financing activities over 3 years is $431666.7, with a median of $375500.0 recorded in 2022.
  • Peak annual rise in Other financing activities hit 72.58% in 2022, while the deepest fall reached 187.71% in 2022.
  • Year by year, Other financing activities stood at $464000.0 in 2021, then plummeted by 133.84% to -$157000.0 in 2022, then skyrocketed by 342.04% to $380000.0 in 2023.
  • Business Quant data shows Other financing activities for DERM at $380000.0 in Q4 2023, -$157000.0 in Q2 2022, and $371000.0 in Q1 2022.